Gentuity Hf-Oct Imaging System
Payments companies reported to CMS as associated with Gentuity Hf-Oct Imaging System. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Gentuity Hf-Oct Imaging System, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Gentuity Hf-Oct Imaging System
These are the largest totals companies reported as associated with Gentuity Hf-Oct Imaging System. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Hiram Bezerra | Tampa, FL | Cardiovascular Disease | $365,268.25 |
| Eric Osborn | Boston, MA | Interventional Cardiology | $27,712.99 |
| Donald Quimby | Tampa, FL | Interventional Cardiology | $13,471.35 |
| Timothy Henry | Cincinnati, OH | Interventional Cardiology | $6,410.03 |
| Ryan Madder | Royal Oak, MI | Interventional Cardiology | $4,578.79 |
| Bernardo Cortese | Cleveland, OH | Interventional Cardiology | $3,128.79 |
| Evan Shlofmitz | Roslyn, NY | Interventional Cardiology | $2,982.26 |
| Ricardo Hanel | Jacksonville, FL | Neurological Surgery | $2,002.79 |
| Morton Kern | Orange, CA | Cardiovascular Disease | $1,825.02 |
| Matthew Price | La Jolla, CA | Interventional Cardiology | $1,661.19 |
Prescribed Gentuity Hf-Oct Imaging System?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.